Thiamine (B1)

Thiamine (vitamin B1) is the cofactor your cells need to turn food into usable energy. It sits at the entry point of mitochondrial metabolism, where glucose and fats get converted into ATP. Without enough of it, every cell in your body is running slow, and the ones most affected are the ones with the highest energy demand: brain, heart, nerves, and the autonomic nervous system that runs digestion, blood pressure, and temperature regulation.

Frank deficiency (beriberi, Wernicke's encephalopathy) is rare in developed countries but functional shortfalls are not. The people who tend to benefit most from supplementation are those with persistent fatigue, brain fog, exercise intolerance, autonomic symptoms (dizziness on standing, sluggish digestion, temperature dysregulation), or diabetic nerve symptoms. Alcohol use, gut dysfunction, diuretics, metformin, high-carb diets, and chronic stress all deplete it. If your bloodwork looks fine but you feel like the lights are dim, thiamine is one of the more underrated levers to pull.

The wrinkle is that standard thiamine HCl, the form in most B-complexes, is poorly absorbed at higher doses and doesn't cross cell membranes or the blood-brain barrier efficiently. The fat-soluble derivatives, benfotiamine and TTFD, were developed specifically to get around this and are what most of the higher-dose protocols use.

Knowing whether you're actually low is harder than it should be. Serum thiamine, the test most doctors run, is close to useless, it reflects recent intake, not what's inside your cells. Whole-blood thiamine (RBC thiamine diphosphate) is the better test but rarely available in standard labs, you'll usually need a functional medicine panel or send-out test. Most people end up figuring it out backwards: they have the phenotype (persistent fatigue, brain fog, autonomic symptoms, often with a history of high-carb diet, gut issues, alcohol, or chronic stress), they run a properly cofactored protocol for 4-8 weeks, and they either feel meaningfully better or they don't.

Deep-dive

Thiamine is the cofactor for three enzymes that sit at the entry points of mitochondrial energy production: pyruvate dehydrogenase (PDH), alpha-ketoglutarate dehydrogenase (αKGDH), and transketolase. PDH converts pyruvate into acetyl-CoA, the fuel that enters the Krebs cycle. αKGDH keeps the Krebs cycle turning. Transketolase runs the pentose phosphate pathway, which makes NADPH (for antioxidant defence) and ribose (for DNA and RNA). When thiamine is even mildly low inside the cell, all three of these reactions slow down. The cell can't burn glucose properly, lactate accumulates, antioxidant capacity drops, and the autonomic nervous system, which is unusually thiamine-dependent, starts misbehaving.

Why you can be functionally low with normal bloodwork. Thiamine HCl, the standard form, is poorly absorbed above about 5 mg per dose. Passive diffusion takes over and you only get a fraction of what you swallow into circulation. From there, getting it across cell membranes and into the brain requires active transporters that are easily downregulated by inflammation, gut dysfunction, insulin resistance, and alcohol. The implication is that serum thiamine, the test most labs run, often looks fine even when intracellular status is poor. Whole-blood thiamine and erythrocyte transketolase activity are better proxies but rarely available in standard panels.

The fat-soluble derivatives. Benfotiamine is a lipid-soluble S-acyl prodrug developed in Japan in the 1950s. It's hydrolysed in the gut to S-benzoylthiamine, which crosses cell membranes by passive diffusion and converts to thiamine inside the cell. It produces blood thiamine levels several-fold higher than equivalent HCl and concentrates strongly in peripheral tissues, particularly nerves and blood vessels. It doesn't cross the blood-brain barrier well, which is both a limitation (less central effect) and a feature (less risk of overstimulation). TTFD (thiamine tetrahydrofurfuryl disulfide) is a disulfide derivative that crosses cell membranes including the blood-brain barrier and is cleaved intracellularly to release thiamine. TTFD is the form used for brain, autonomic, and energy symptoms. Allithiamine, the original fat-soluble form from garlic, behaves similarly to TTFD but is less commonly sold. Sulbutiamine is another disulfide derivative marketed more as a nootropic.

Diabetic neuropathy is where benfotiamine has the strongest data. The mechanism is direct: high glucose damages nerves and blood vessels by shunting metabolites into the polyol, hexosamine, PKC, and AGE pathways, all of which transketolase can divert back into the safer pentose phosphate pathway when thiamine is abundant. In a 3-week placebo-controlled trial of 40 patients, 400 mg/day of benfotiamine improved neuropathy symptom scores. The larger BENDIP trial of 165 patients found 600 mg/day produced significant symptom improvement at 6 weeks, with the effect more pronounced at the higher dose. The BOND trial, a 12-month phase II study published in 2025, was the most rigorous attempt and notably failed to find an effect on objective nerve measures in patients with mild-to-moderate symptomatic neuropathy. A 24-month trial in type 1 diabetics at 300 mg/day also found no benefit, though those patients started with near-normal nerve function. Net read: benfotiamine helps neuropathy symptoms in the short to medium term in symptomatic patients, the longer-term structural case is unproven.

Fatigue in autoimmune and inflammatory disease. A randomised crossover trial in 40 IBD patients gave 600-1800 mg of oral thiamine HCl daily for 4 weeks and found a mean 4.5-point reduction in fatigue scores versus a slight increase on placebo, with the benefit independent of baseline thiamine status. A later crossover trial in primary biliary cholangitis used the same protocol and found a meaningful reduction in fatigue. Earlier case series by Antonio Costantini covered Hashimoto's, multiple sclerosis, post-stroke fatigue, fibromyalgia, and early Parkinson's, with consistent improvements at doses of 600-1800 mg oral or 100 mg IM twice weekly. The case series were small and open-label, but the IBD and PBC RCTs are properly controlled and positive.

Alzheimer's and mild cognitive impairment. Thiamine-dependent glucose metabolism is impaired early in Alzheimer's, and the question is whether flooding the system can partially restore it. The Burke Phase IIa trial gave 600 mg/day of benfotiamine for 12 months to 70 patients with amnestic MCI or mild AD dementia. It missed its primary cognitive endpoint but showed a trend toward slowing decline and improved a secondary clinical rating, leading to the much larger phase 2A-2B BenfoTeam trial currently underway with 406 participants on 600 or 1200 mg/day. Suggestive, not yet proven.

Exercise and motivation. A mouse study found TTFD at 50-100 mg/kg reduced exercise-induced muscle damage markers and increased glycogen storage. A separate rat study found 50 mg/kg TTFD increased voluntary running through dopamine D1 activation in the medial prefrontal cortex, the first mechanistic suggestion that TTFD has a direct dopaminergic effect on motivation in addition to its mitochondrial role. Human exercise data is thin and the doses don't translate cleanly.

Frank deficiency states. Wernicke's encephalopathy (confusion, ataxia, eye movement abnormalities) and dry/wet beriberi are medical emergencies requiring IV thiamine in the hundreds of milligrams, not supplements. Risk groups include heavy alcohol use, post-bariatric surgery, persistent vomiting including hyperemesis gravidarum, and severe malnutrition. Anyone in these groups developing neurological symptoms should be in an ER.

Women. The clinical trial base in IBD and PBC fatigue has included roughly equal numbers of men and women with similar responses, and the BENDIP neuropathy trial had majority-male enrolment but no signal of sex-differentiated response. There's no biological reason to expect a different mechanism, all the relevant enzymes are sex-independent. Practical differences worth noting: hormonal birth control mildly depletes thiamine in some women, pregnancy raises thiamine requirements (and severe morning sickness can drive frank deficiency), and the postnatal period in breastfeeding mothers tends to raise B-vitamin needs. None of this is a reason to dose differently, but it's a reason women in those phases are slightly more likely to be running low. In perimenopause and menopause, the fatigue and autonomic symptoms that can come with hormonal shifts overlap heavily with the functional-thiamine-shortfall phenotype, and a trial run is reasonable.

Older adults. Thiamine status declines with age, both from lower intake and from reduced absorption. Older adults with persistent fatigue, balance issues, or early cognitive symptoms are exactly the population the Alzheimer's trials are targeting. Start low, build up slowly, and pair with B12 and folate which often need attention in the same group.

Caveats on the broader evidence. Most of the higher-dose fatigue research comes out of a small number of research groups and the original Costantini work was largely open-label. The benfotiamine neuropathy literature is solid for short-term symptom relief but has flunked the longer structural endpoints. The Alzheimer's work is promising but unproven. The practical case for a trial run is reasonable given the wide safety margin, but the confidence interval on the upside is wider than the marketing suggests.

Dosage:

Standard maintenance (B-complex or standalone): the RDA is 1.1-1.2 mg/day. Most quality B-complexes deliver 25-100 mg of thiamine HCl, which is plenty for general use and covers anyone eating a varied diet

Higher-dose thiamine HCl: 500-1500 mg/day for women, 1000-1800 mg/day for men, taken in divided doses with food. This is the Costantini-style protocol and the form used in the IBD and PBC fatigue RCTs. Cheap, well-tolerated, less cellular penetration per milligram than the fat-soluble derivatives

Benfotiamine: 150-300 mg twice daily (300-600 mg/day) is the standard range. Go up to 1200 mg/day for diabetic neuropathy or cognitive use, matching trial doses. Taken with food. Better tolerated than TTFD because it doesn't cross the blood-brain barrier as readily, fewer central effects in the first few weeks

TTFD: start at 50 mg once daily with food, work up to 100-300 mg/day in divided doses over 2-4 weeks. This is the form for brain, autonomic, and energy symptoms. Stronger and more activating, more likely to produce paradoxical reactions, requires careful cofactor support

Cofactors are not optional at higher doses. Magnesium glycinate or malate at 200-400 mg elemental daily, a quality B-complex (especially riboflavin, B6, B12), and adequate dietary potassium. Without these, TTFD especially will pull cofactors from their stores and create new bottlenecks, the classic paradoxical reaction

Timing: with food, earlier in the day. TTFD can be mildly activating and is best avoided in the evening. Benfotiamine and HCl are generally neutral on sleep

Older adults: start at half the standard dose and titrate slower. Sensitivity is higher and cofactor stores are often lower

Cycling: no firm consensus. Continuous protocols are common at the lower end. Some run 3 months on, 1 month off at higher TTFD doses. Reasonable middle ground: titrate up, hold at the dose that produces the response, drop to a maintenance dose (50-100 mg TTFD or 150-300 mg benfotiamine) once symptoms stabilise

Pregnancy and breastfeeding: standard prenatal thiamine intake is adequate. Pharmacologic doses haven't been studied in pregnancy and should be a medical decision, not a self-experiment. Hyperemesis gravidarum is a separate medical issue

Here's what you can expect:

At standard maintenance doses (a B-complex or 25-100 mg HCl), you'll notice nothing specific unless you were genuinely low to start with, in which case fatigue and brain fog tend to lift over 2-4 weeks.

At higher pharmacologic doses (300+ mg benfotiamine or 50+ mg TTFD), if you're the right phenotype (persistent fatigue or brain fog not explained by sleep, thyroid, or iron), the first two weeks often produce a noticeable lift in energy, cleaner thinking, and a sense that the autonomic system has settled, steadier heart rate, better tolerance of standing, more reliable digestion. Some people describe it as the lights coming back up. The full effect, particularly for fatigue and neuropathy symptoms, tends to land around 4-8 weeks.

A significant minority experience a paradoxical reaction in the first days at higher doses, sometimes called the refeeding-like response: temporary worsening of fatigue, anxiety, irritability, brain fog, or muscle aches as cellular metabolism speeds up and pulls magnesium, potassium, and other B vitamins faster than the body can supply them. This is the main reason starting low and front-loading magnesium is non-negotiable at higher doses. The reaction usually resolves within a week or two of staying the course with proper cofactor support. If it doesn't, the dose is too high or a cofactor is missing.

If you're not the right phenotype (well-rested, well-fed, no autonomic or fatigue symptoms), you'll likely notice nothing beyond perhaps slightly better workout recovery, and there's no strong case for daily high-dose use.

Side effects & risks:

Paradoxical reaction in the first 1-2 weeks at higher doses is the most common complaint, especially with TTFD. Fatigue, anxiety, irritability, sleep disruption, muscle cramps. Almost always a sign that magnesium or other cofactors aren't keeping up. Start low, load magnesium first, slow the titration

Sulfur sensitivity. TTFD contains a disulfide bond and releases sulfur metabolites. People with sulfur sensitivity, low molybdenum, or CBS pathway issues can react with brain fog, irritability, body odour, or GI symptoms. Benfotiamine doesn't have this problem and is the alternative if TTFD doesn't agree with you

GI discomfort, nausea, mild rash at higher doses. Usually resolves with dose reduction or splitting

Strong odour from TTFD, particularly in sweat and urine, is normal. Some people find it noticeable, others don't

Anxiety or insomnia if TTFD is dosed too late in the day, given its mild dopaminergic effect

Drug interactions. Thiamine status is depleted by loop diuretics (furosemide), metformin (mildly), chronic alcohol, and some chemotherapy agents. Those on long-term loop diuretics or metformin often benefit from thiamine supplementation independent of any other reason. No major direct interactions with common medications

Wilson's disease and hereditary thiamine transporter disorders are special cases requiring medical management, not self-dosing

Genuine toxicity is rare. Thiamine has an extremely wide safety margin in the standard literature. The realistic risks at higher doses are cofactor depletion, sulfur reactions, and over-stimulation, not toxicity itself

If you don't respond within 6-8 weeks of a properly cofactored higher-dose protocol, the issue probably isn't thiamine and continuing won't help. Look at thyroid, iron, B12, sleep, and adrenal function before assuming you need more

🩸

Blood markers

Whole-blood thiamine or erythrocyte transketolase activity, baseline if you can get them. Serum thiamine reflects recent intake, not cellular status, and is largely useless for assessing functional shortfall. Whole-blood is the better proxy for what's actually in tissues. Most standard labs won't run it, you'll need a functional medicine panel or send-out test. Recheck at 3 months if running high doses long-term.

Magnesium (RBC magnesium ideally, not serum), baseline. Magnesium is the most common cofactor bottleneck and serum magnesium misses cellular depletion. If RBC magnesium isn't available, treat any value in the lower half of the serum range as suggestive of deficiency given how common it is.

HbA1c, fasting glucose, fasting insulin, baseline. Glucose dysregulation is one of the main reasons people end up functionally thiamine-deficient and benfotiamine is most useful when these markers are off.

Full B-vitamin panel where possible (B12, folate, methylmalonic acid, homocysteine), baseline. B12 deficiency is common, easily missed, and produces overlapping symptoms. You don't want to be chasing the wrong vitamin.

TSH, free T4, free T3, baseline. Hypothyroidism is the other top differential for the fatigue-and-brain-fog phenotype and worth ruling out before assuming thiamine is the answer.

Liver enzymes (ALT, AST, GGT), baseline, particularly if there's any history of alcohol use. Liver function affects thiamine activation and storage.

For most people at maintenance doses, no specific bloodwork is needed. For anyone running pharmacologic doses for fatigue, neuropathy, or cognitive support, a basic metabolic panel, HbA1c, B12, folate, and a thyroid panel cover the differential. Whole-blood thiamine is the speciality test worth running if you want a real baseline to track against.

Thiamine and its derivatives are sold as dietary supplements in most countries without prescription.